Skip to main content
. 2017 Sep 19;12(9):e0184510. doi: 10.1371/journal.pone.0184510

Fig 3. Molecular mechanisms of resistance to first- and second-line anti-TB drugs.

Fig 3

A heatmap showing the phenotypic susceptibility profiles to first- and second-line anti-TB drugs and the presence of known resistance mutations. Blue = phenotypically susceptible, Red = phenotypically resistant, Black = presence of resistance mutation, white = absence of resistance mutation and grey = no phenotypic testing.